JP7334266B2 - 眼疾患治療用の組成物および方法 - Google Patents

眼疾患治療用の組成物および方法 Download PDF

Info

Publication number
JP7334266B2
JP7334266B2 JP2021565092A JP2021565092A JP7334266B2 JP 7334266 B2 JP7334266 B2 JP 7334266B2 JP 2021565092 A JP2021565092 A JP 2021565092A JP 2021565092 A JP2021565092 A JP 2021565092A JP 7334266 B2 JP7334266 B2 JP 7334266B2
Authority
JP
Japan
Prior art keywords
antibiotic
ophthalmic composition
hyaluronic acid
hydrogel
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021565092A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022530837A5 (https=
JP2022530837A (ja
Inventor
ケイ． マン、ブレンダ
イ、ヒ－キョン
Original Assignee
アイゲート ファーマスーティカルズ，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アイゲート ファーマスーティカルズ，インコーポレイテッド filed Critical アイゲート ファーマスーティカルズ，インコーポレイテッド
Publication of JP2022530837A publication Critical patent/JP2022530837A/ja
Publication of JP2022530837A5 publication Critical patent/JP2022530837A5/ja
Application granted granted Critical
Publication of JP7334266B2 publication Critical patent/JP7334266B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2021565092A 2019-05-03 2020-04-30 眼疾患治療用の組成物および方法 Active JP7334266B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962842995P 2019-05-03 2019-05-03
US62/842,995 2019-05-03
PCT/US2020/030691 WO2020227002A1 (en) 2019-05-03 2020-04-30 Compositions and methods for treatment of ocular diseases

Publications (3)

Publication Number Publication Date
JP2022530837A JP2022530837A (ja) 2022-07-01
JP2022530837A5 JP2022530837A5 (https=) 2023-05-12
JP7334266B2 true JP7334266B2 (ja) 2023-08-28

Family

ID=70861542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021565092A Active JP7334266B2 (ja) 2019-05-03 2020-04-30 眼疾患治療用の組成物および方法

Country Status (9)

Country Link
US (2) US11376214B2 (https=)
EP (1) EP3962452A1 (https=)
JP (1) JP7334266B2 (https=)
KR (2) KR102649858B1 (https=)
CN (1) CN114025742A (https=)
CA (1) CA3139060A1 (https=)
IL (1) IL287802B2 (https=)
MX (1) MX2021013447A (https=)
WO (1) WO2020227002A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10945858B2 (en) * 2010-09-03 2021-03-16 Globus Medical, Inc. Expandable interspinous process fixation device
GB202008857D0 (en) * 2020-06-11 2020-07-29 Univ Birmingham Fluid gel compositions
GB202008853D0 (en) * 2020-06-11 2020-07-29 Univ Birmingham Fluid gel compositions
CN112587475B (zh) * 2020-12-18 2022-09-13 华熙生物科技股份有限公司 一种载药凝胶及其制备方法
DE102023116924A1 (de) * 2023-06-27 2025-01-02 Carl Zeiss Meditec Ag Kit zur Verwendung in einer Augenoperation und ophthalmische viskoelastische Vorrichtung
WO2025155730A1 (en) * 2024-01-16 2025-07-24 Regents Of The University Of Minnesota Injectable hydrogel for embolization

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140341842A1 (en) 2013-05-14 2014-11-20 Bio Time, Inc. Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione
WO2019046834A1 (en) 2017-09-01 2019-03-07 Pmidg, Llc FUNCTIONALIZED AND RETICULATED POLYMERS
WO2019057035A1 (en) 2017-09-19 2019-03-28 The Hong Kong University Of Science And Technology BIOCOMPATIBLE MATERIAL AND METHODS OF MAKING AND USING THE SAME

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE312076T1 (de) * 2001-02-22 2005-12-15 Anika Therapeutics Inc Thiol-modifizierte hyaluronan-derivate
CA2703807C (en) * 2010-05-12 2017-10-24 Molly S. Shoichet Enhanced stability of inverse thermal gelling composite hydrogels
US9782345B2 (en) * 2013-10-17 2017-10-10 Jade Therapeutics, Inc. Ocular composition and method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140341842A1 (en) 2013-05-14 2014-11-20 Bio Time, Inc. Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione
WO2019046834A1 (en) 2017-09-01 2019-03-07 Pmidg, Llc FUNCTIONALIZED AND RETICULATED POLYMERS
WO2019057035A1 (en) 2017-09-19 2019-03-28 The Hong Kong University Of Science And Technology BIOCOMPATIBLE MATERIAL AND METHODS OF MAKING AND USING THE SAME

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ADVANCES IN WOUND CARE，2014年，Vol.3(11)，pp.708-716
Proceedings of The National Conference On Undergraduate Research (NCUR) 2016，2016年，p.1065-1071

Also Published As

Publication number Publication date
IL287802B1 (en) 2024-05-01
MX2021013447A (es) 2022-02-11
KR20220004753A (ko) 2022-01-11
WO2020227002A1 (en) 2020-11-12
CA3139060A1 (en) 2020-11-12
IL287802A (en) 2022-01-01
CN114025742A (zh) 2022-02-08
US20200345634A1 (en) 2020-11-05
US11376214B2 (en) 2022-07-05
KR20240038152A (ko) 2024-03-22
JP2022530837A (ja) 2022-07-01
EP3962452A1 (en) 2022-03-09
IL287802B2 (en) 2024-09-01
US20220287961A1 (en) 2022-09-15
KR102649858B1 (ko) 2024-03-20

Similar Documents

Publication Publication Date Title
JP7334266B2 (ja) 眼疾患治療用の組成物および方法
EP3612228B1 (en) Iodine compositions
CN107847604B (zh) 眼用原位凝胶处方
JP5745666B2 (ja) 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用
EA025414B1 (ru) Фармацевтическая композиция для применения в медицинской и ветеринарной офтальмологии
JP2004510809A (ja) 眼を処置するための局所用抗生物質組成物
Alase Sustained ophthalmic delivery of gatifloxacin from in situ gelling system
US20210322396A1 (en) Compositions with synergistic permeation enhancers for drug delivery
EP4021402B1 (en) Thixotropic delivery systems
JP2023518972A (ja) 眼病態の治療のための組成物及び方法
JP2012523450A (ja) 硫酸フラミセチンクリーム剤およびキトサンを使用して製造された薬用クリーム剤ならびにそれを製造する方法
EP4404949A1 (en) Ophthalmic compositions and methods of using same
RU2531937C2 (ru) Состав и способ получения глазной мази
CA3119363A1 (en) Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
柿栖康二 et al. Development and efficacy of a drug-releasing soft contact lens
HK40024598A (en) Iodine compositions
HK40024598B (en) Iodine compositions
HK1248100B (zh) 眼用原位凝胶处方

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230501

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230501

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230501

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230718

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230816

R150 Certificate of patent or registration of utility model

Ref document number: 7334266

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150